ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 174 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $505,000 | -37.5% | 18,005 | -42.0% | 0.00% | -33.3% |
| Q4 2020 | $808,000 | -30.1% | 31,067 | -0.1% | 0.00% | -40.0% |
| Q3 2020 | $1,156,000 | -27.5% | 31,092 | 0.0% | 0.01% | -37.5% |
| Q2 2020 | $1,595,000 | +61.6% | 31,092 | -0.7% | 0.01% | +33.3% |
| Q1 2020 | $987,000 | -59.0% | 31,317 | -22.5% | 0.01% | -50.0% |
| Q4 2019 | $2,408,000 | +40.7% | 40,385 | -13.5% | 0.01% | +33.3% |
| Q3 2019 | $1,712,000 | +33.8% | 46,690 | +69.7% | 0.01% | +28.6% |
| Q2 2019 | $1,280,000 | +459.0% | 27,520 | +770.9% | 0.01% | +600.0% |
| Q1 2018 | $229,000 | – | 3,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |